The MIMS website is updated constantly, providing news on drug launches and licence changes together with clinical guideline updates.
MIMS quarterly print publication
The MIMS book is published every quarter and is sent free of charge to the practice addresses of all UK-based GPs who complete our online registration form .
If you have already registered and need to change your mailing address, please call 0845 136 93 16 or email firstname.lastname@example.org including your name, surgery address and GMC number.
Other relevant healthcare professionals may subscribe to MIMS by emailing email@example.com .
MIMS mobile and tablet applications
MIMS is available as an app for Apple and Android devices for only £9.99 a year. MIMS won the PPA digital directory of the year in 2012. Download it now to receive over 300 updates every month.
MIMS online is part of the GPonline network of sites. The online version of MIMS contains additional resources and registration provides GPs with free access to the MIMS database of drugs and products.
MIMS online content
- MIMS database drug search : search the MIMS database for drug information including indications, doses, side effects, interactions, contraindications and warnings. Browse drugs by therapeutic area or use the search box to extend your search to tables, guidelines, patient resources and news.
- Latest medical news : New drugs | Licence changes and product updates | Guidelines and clinical updates
- Quick reference tables : clinical and comparison tables ordered by therapeutic area.
- Clinical guidelines including NICE guidance : over 140 clinical guideline summaries browsable by therapeutic area .
- Travel vaccination and malaria prophylaxis advice : latest immunisation recommendations and antimalarial regimens ordered A-Z by country.
- Clinical calculators : links to simple but essential clinical calculators for body mass index (BMI) , baby's age , pregnancy due date and more.
- Pharmaceutical manufacturers : find the products produced by a drug company, organised alphabetically by company name.
Further information about MIMS
A meta-analysis of 522 trials involving 116,477 people has found that 21 common antidepressants were all more effective at reducing symptoms of acute depression than placebo.
Brabio (glatiramer acetate) is a generic version of Copaxone which provides a potentially cheaper alternative treatment for relapsing multiple sclerosis (MS).
Opioid prescribing in England increased from 2010 to 2014 despite these drugs increasingly being considered ineffective in the treatment of chronic non-cancer pain, a study published in the British Journal of General Practice has shown.
New temporary safety measures have been introduced for Esmya (ulipristal acetate) following reports of serious liver injury in women using the medicine to treat uterine fibroids.
Ocrevus (ocrelizumab) is the first disease-modifying agent to be licensed for the treatment of both relapsing and primary progressive forms of multiple sclerosis (MS).
- Salaried GP and Maternity Locum Postions Salford Care Centres Manchester, Greater Manchester
- GP Partner Position Thurso & Halkirk Medical Practice Thurso, Highland
- Salaried GP – 2/3 sessions Liphook Village Surgery Liphook, Hampshire
- Part time GP Partner Rotherham Road Medical Centre Barnsley, South Yorkshire
- Salaried GP with a view to partnership Radnor House Surgery Ascot, Berkshire